Deswal, Anita
The University of Texas MD Anderson Cancer Center
16 papers on CoChatORCID 0000-0002-6147-9591
Most cited papers
- Verified · note
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology
Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors
Cited by 2,862
- Verified · note
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Journal of the American College of Cardiology
Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management
Cited by 933
- Verified
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology
Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors
Cited by 931
- Verified
Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update
Dunlay, S. M., Givertz, M. M., Aguilar, D., Allen, L. A., Chan, M., Desai, A. S., Deswal, A., Dickson, V. V., Kosiborod, M. N., Lekavich, C. L., et al. (2019) · Circulation
Heart Failure Treatment and ManagementDiabetes Treatment and Management
Cited by 639
- Verified
2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction
Kittleson, M. M., Panjrath, G. S., Amancherla, K., Davis, L. L., Deswal, A., Dixon, D. L., Januzzi, J. L., & Yancy, C. W. (2023) · Journal of the American College of Cardiology
Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors
Cited by 554
- Verified
Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment
Palaskas, N., Lopez‐Mattei, J., Durand, J. B., Iliescu, C., & Deswal, A. (2020) · Journal of the American Heart Association
Cancer Immunotherapy and BiomarkersViral Infections and Immunology Research
Cited by 535
- Verified
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Writing Committee Members, Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., et al. (2020) · Circulation
Cardiomyopathy and Myosin StudiesCardiovascular Effects of Exercise
Cited by 336
- Verified
Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization: The LINK-HF Multicenter Study
Stehlik, J., Schmalfuss, C., Bozkurt, B., Nativi-Nicolau, J., Wohlfahrt, P., Wegerich, S., Rose, K., Ray, R., Schofield, R., Deswal, A., et al. (2020) · Circulation Heart Failure
Heart Failure Treatment and ManagementNon-Invasive Vital Sign Monitoring
Cited by 333
- Verified
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study
Givertz, M. M., Anstrom, K. J., Redfield, M. M., Deswal, A., Haddad, H., Butler, J., Tang, W. H. W., Dunlap, M. E., LeWinter, M. M., Mann, D. L., et al. (2015) · Circulation
Gout, Hyperuricemia, Uric AcidHeart Failure Treatment and Management
Cited by 296
- Verified
2020 ACC/AHA guideline for the management of patients with valvular heart disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · The Journal of Thoracic and Cardiovascular Surgery
Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches
Cited by 279
- Verified
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor–Associated Myocarditis: A Narrative Review
Lehmann, L. H., Cautela, J., Palaskas, N., Baik, A. H., Meijers, W. C., Allenbach, Y., Alexandre, J., Rassaf, T., Müller, O. J., Aras, M., et al. (2021) · JAMA Cardiology
Cancer Immunotherapy and BiomarkersViral Infections and Immunology Research
Cited by 178
- Verified
Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis
Lehmann, L. H., Heckmann, M. B., Bailly, G., Finke, D., Procureur, A., Power, J. R., Stein, F., Bretagne, M., Ederhy, S., Fenioux, C., et al. (2023) · Circulation
Cancer Immunotherapy and BiomarkersViral Infections and Immunology Research
Cited by 165
- Verified
Type 2 diabetes mellitus and heart failure, a scientific statement from the American Heart Association and Heart Failure Society of America
Dunlay, S. M., Givertz, M. M., Aguilar, D., Allen, L. A., Chan, M., Desai, A. S., Deswal, A., Dickson, V. V., Kosiborod, M. N., Lekavich, C. L., et al. (2019) · Journal of Cardiac Failure
Heart Failure Treatment and ManagementDiabetes Treatment and Management
Cited by 145
- Verified
Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus
Aguilar, D., Deswal, A., Ramasubbu, K., Mann, D. L., & Bozkurt, B. (2010) · The American Journal of Cardiology
Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors
Cited by 96
- Verified
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
Fenioux, C., Abbar, B., Boussouar, S., Bretagne, M., Power, J. R., Moslehi, J. J., Gougis, P., Amelin, D., Dechartres, A., Lehmann, L. H., et al. (2023) · Nature Medicine
Cancer Immunotherapy and BiomarkersMyasthenia Gravis and Thymoma
Cited by 83
- Verified
Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis
Power, J. R., Alexandre, J., Choudhary, A., Ozbay, B., Hayek, S. S., Asnani, A., Tamura, Y., Aras, M., Cautela, J., Thuny, F., et al. (2022) · Archives of Cardiovascular Diseases
Viral Infections and Immunology ResearchCancer Immunotherapy and Biomarkers
Cited by 43
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free